Global Compounding Pharmacies Market Booms as Personalized Medicine Surges

Got story updates? Submit your updates here. ›

The global compounding pharmacies market is witnessing robust growth, projected to reach $29.2 billion by 2036 at a CAGR of 7.6%. This expansion is driven by the rising demand for personalized medicines and patient-specific treatment solutions, as healthcare systems increasingly prioritize individualized care. Compounding pharmacies play a critical role in preparing customized medications tailored to individual needs, including dosage adjustments, allergen-free formulations, and alternative delivery methods.

Why it matters

The growing emphasis on personalized medicine is a key factor fueling demand for compounding pharmacies. As treatment protocols evolve and the prevalence of chronic diseases rises, especially in aging populations, compounding pharmacies are becoming an essential extension of clinical care, enabling flexible dosage customization and improving patient adherence.

The details

Oral compounded medications dominate the market, accounting for 46% of share in 2026, due to their compatibility with routine prescription practices and ease of administration. Medication for adults leads the application segment with 56.7% share, supported by the higher burden of chronic diseases and increased need for long-term treatment customization. The competitive landscape is evolving with continuous innovation and strategic partnerships, including expansion of non-sterile compounding capabilities, collaborations to accelerate innovation, and increased regulatory focus on quality and compliance.

• The global compounding pharmacies market is projected to grow from $14,040.1 million in 2026 to $29,207.4 million by 2036.
• The market is expected to register a CAGR of 7.6% during the forecast period from 2026 to 2036.

What’s next

The compounding pharmacies market is poised for sustained growth as healthcare systems increasingly prioritize individualized treatment, precision dosing, and patient-centric care models. Advancements in formulation science, integration with telehealth platforms, and growing acceptance of personalized therapies will continue to reshape the pharmaceutical landscape, further driving demand for customized medication solutions.